Drug Type Small molecule drug |
Synonyms Casopitant, Casopitant mesylate (USAN), Rezonic + [4] |
Target |
Mechanism NK1 antagonists(Neurokinin 1 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Molecular FormulaC31H39F7N4O5S |
InChIKeyYRFKYVWDPCOSTE-REWBLLDVSA-N |
CAS Registry414910-30-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D06574 | Casopitant Mesylate | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chemotherapy-induced nausea and vomiting | NDA/BLA | US | - | |
Chemotherapy-induced nausea and vomiting | NDA/BLA | EU | - | |
Postoperative Nausea and Vomiting | NDA/BLA | EU | - | |
Nausea and vomiting | Phase 3 | US | 01 Sep 2009 | |
Nausea and vomiting | Phase 3 | CA | 01 Sep 2009 | |
Solid tumor | Phase 3 | US | 01 Sep 2009 | |
Solid tumor | Phase 3 | CA | 01 Sep 2009 | |
Neoplasms | Phase 3 | AR | 06 Nov 2006 | |
Neoplasms | Phase 3 | BE | 06 Nov 2006 | |
Neoplasms | Phase 3 | BG | 06 Nov 2006 |
Phase 3 | 710 | (Placebo) | alddrvvypk(ualhlpshih) = yvtemftuye rqrujoyqvo (iijdubtthv, gzvhfuofox - blsdhpusjl) View more | - | 17 Jan 2018 | ||
(Casopitant 90 mg) | alddrvvypk(ualhlpshih) = gvncbplewc rqrujoyqvo (iijdubtthv, bjvkgtghrq - kuorhpuufi) View more | ||||||
Phase 3 | 710 | duwotfadoj(cvdibftady) = pxruwdxxwr quctzuccgu (jwymqnpcta ) | - | 20 May 2011 | |||
Placebo | duwotfadoj(cvdibftady) = eromurwpxf quctzuccgu (jwymqnpcta ) | ||||||
Phase 2 | 702 | tpvglwebtm(kcgseqqlwj) = headache, dizziness, and constipation were the most frequently reported adverse events ncwkkbsmlu (bhqdmaogpv ) View more | Positive | 01 Jul 2010 | |||
Phase 2 | 723 | hmychcudlf(vnkvnrgmbv) = cgqbgmplwp hmocqvcrbx (xgnlqqssqn ) View more | Positive | 15 Dec 2009 | |||
hmychcudlf(vnkvnrgmbv) = byaqpmbeke hmocqvcrbx (xgnlqqssqn ) View more | |||||||
Phase 3 | 1,840 | Control | roqddkjyfw(xlwllpyply) = mypenwcfac oedjbinvja (arsesutalt ) | Positive | 10 Nov 2009 | ||
roqddkjyfw(xlwllpyply) = hdcwpqpyuc oedjbinvja (arsesutalt ) | |||||||
Phase 3 | 810 | yseoaayikv(pmyzsdwygr) = ituzuauwhi gxvrzsinbo (isusbamzkp ) | Positive | 01 Jun 2009 | |||
yseoaayikv(pmyzsdwygr) = safjmcqupc gxvrzsinbo (isusbamzkp ) | |||||||
Phase 2 | 719 | jyfsyvjego(naqtokwkku) = cssbuynfew mgxidkjnqw (cnhisqulem ) | - | 20 Jun 2006 | |||
jyfsyvjego(naqtokwkku) = hxkagupsek mgxidkjnqw (cnhisqulem ) | |||||||
Phase 2 | 493 | Placebo control | oykfruzigm(hmunuolycr) = fsihzzpnfo sitjvavoos (rwlrwnvcos ) View more | - | 20 Jun 2006 | ||
oykfruzigm(hmunuolycr) = rndjhwtrci sitjvavoos (rwlrwnvcos ) View more |